Sera Prognostics (SERA) Short term Debt (2020)

Sera Prognostics (SERA) posted Short term Debt of $4.4 million for Q4 2020.

Sera Prognostics (SERA) Short term Debt (2020) Analysis & Trends

Sera Prognostics' Short term Debt history runs 1 years deep, the most recent figure standing at $4.4 million for Q4 2020.

  • Quarterly Short term Debt changed N/A year-over-year to $4.4 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $4.4 million (changed N/A YoY) and the FY2020 annual result came in at $4.4 million, changed N/A from the prior year.
  • Short term Debt was $4.4 million for Q4 2020 at Sera Prognostics.
  • Across five years, Short term Debt topped out at $4.4 million in Q4 2020 and bottomed at $4.4 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.44 Bn 175.14 Bn 6.27 Bn
2 Stryker 128.87 Bn 125.99 Bn 3.81 Bn
3 Medtronic 108.10 Bn 98.88 Bn 6.41 Bn
4 Boston Scientific 67.99 Bn 66.53 Bn 3.61 Bn
5 Edwards Lifesciences 48.22 Bn 44.55 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.15 Bn 750.30 Mn
7 GE HealthCare Technologies 28.02 Bn 25.74 Bn 1.98 Bn
8 Smith & Nephew 27.01 Bn 26.43 Bn -
9 Koninklijke Philips 23.74 Bn 20.62 Bn 2.07 Bn
10 Sera Prognostics 107.05 Mn 107.05 Mn -28,000.00

Historic Data

Download Data
DateValue
Dec 31, 2020 4.35 Mn